Sign Up to like & get
recommendations!
1
Published in 2020 at "Clinical and Experimental Dermatology"
DOI: 10.1111/ced.14379
Abstract: We read with interest Molloy et al's letter describing a patient with recalcitrant nodular prurigo (NP) responding to tofacitinib.1 While we recognise the IL-31 and IL-4 mediated therapeutic potential of tofacitinib to inhibit pruritus, our…
read more here.
Keywords:
recalcitrant nodular;
successful treatment;
nodular prurigo;
comment successful ... See more keywords